Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-08T14:22:48.341Z Has data issue: false hasContentIssue false

Use of magnetic resonance imaging and computed tomography

Published online by Cambridge University Press:  01 May 2009

Jeffrey A. Feinstein*
Affiliation:
Lucile Packard Children’s Hospital, Stanford University Medical Center, Palo Alto, California, United States of America
Michael A. Gatzoulis
Affiliation:
Royal Brompton Hospital, and the National Heart & Lung Institute, Imperial College, London, United Kingdom
*
Correspondence to: Jeffrey A. Feinstein, MD, MPH, Associate Professor, Pediatrics and, by courtesy, BioEngineering, Director, Vera Moulton Wall Center for Pulmonary Vascular Disease (http://wallcenter.stanford.edu/), Associate Director, Pediatric and Congenital Cardiac Catheterization, Lucile Packard Children’s Hospital/Stanford University Medical Center, 750 Welch Road – Suite 305/Palo Alto, California 94304, United States of America. Tel: (650) 723 7913; Fax: (650) 725 8343; E-mail: jeff.feinstein@stanford.edu
Rights & Permissions [Opens in a new window]

Abstract

Figure 0

Table 1 Indications for cardiac magnetic resonance in congenital cardiac disease (*).

Figure 1

Figure 1 Survival in patients with idiopathic pulmonary arterial hypertension as a function of cardiac magnetic resonance parameters. LVEDVI, left ventricular end-diastolic volume index; RV, right ventricle; RVEDVI, right ventricular end-diastolic volume index; SVI, systolic volume index. Reproduced with permission from van Wolferen SA et al., Reference 3.

Figure 2

Figure 2 Delayed enhancement is a common finding in patients with pulmonary hypertension of all etiologies. Most commonly seen in the interventricular septum at the “hinge points,” enhancement has also been demonstrated at the site of surgical fibrosis, papillary muscles and right ventricular outflow tract.

Figure 3

Figure 3 Kaplan Meier survival curves demonstrating improved survival with relative area change (RAC, i.e. pulmonary artery compliance measured by magnetic resonance) > 16%. Reproduced with permission from Gan et al., Reference 23.